ASX - Delayed Quote AUD
Genetic Technologies Limited (GTG.AX)
At close: October 16 at 1:07 PM GMT+11
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
7,664.7840
7,664.7840
8,686.1180
6,794.8160
120.5540
Cost of Revenue
3,760.3100
3,760.3100
4,335.2650
3,013.5340
170.4570
Gross Profit
3,904.4740
3,904.4740
4,350.8530
3,781.2820
-49.9030
Operating Expense
16,114.6860
16,114.6860
15,721.7380
12,887.7930
8,151.3240
Operating Income
-12,210.2120
-12,210.2120
-11,370.8850
-9,106.5110
-8,201.2270
Net Non Operating Interest Income Expense
-323.7380
-323.7380
-235.9430
-275.8420
31.4740
Other Income Expense
516.7310
516.7310
-302.4240
2,219.2300
1,092.1340
Pretax Income
-12,017.2190
-12,017.2190
-11,909.2520
-7,163.1230
-7,077.6190
Tax Provision
--
--
-158.3290
-32.1250
--
Net Income Common Stockholders
-12,017.2190
-12,017.2190
-11,750.9230
-7,130.9980
-7,077.6190
Diluted NI Available to Com Stockholders
-12,017.2190
-12,017.2190
-11,750.9230
-7,130.9980
-7,077.6190
Basic EPS
-0.01
--
-0.01
-0.08
-0.08
Diluted EPS
-0.01
--
-0.01
-0.08
-0.08
Basic Average Shares
118,171.6180
--
106,096.1330
96,492.0160
89,415.6060
Diluted Average Shares
118,171.6180
--
106,096.1330
96,492.0160
89,415.6060
Total Operating Income as Reported
-6,084.1070
--
--
--
--
Total Expenses
19,874.9960
19,874.9960
20,057.0030
15,901.3270
8,321.7810
Net Income from Continuing & Discontinued Operation
-12,017.2190
-12,017.2190
-11,750.9230
-7,130.9980
-7,077.6190
Normalized Income
-10,525.9340
-10,525.9340
-9,812.8245
-6,927.6371
-7,055.5740
Interest Income
119.5110
119.5110
220.1610
36.2560
62.3940
Interest Expense
51.6220
51.6220
29.5150
15.2150
16.3380
Net Interest Income
-323.7380
-323.7380
-235.9430
-275.8420
31.4740
EBIT
-11,965.5970
-11,965.5970
-11,879.7370
-7,147.9080
-7,061.2810
EBITDA
-11,430.7090
-11,430.7090
-11,203.1540
-6,569.2400
-6,675.0040
Reconciled Cost of Revenue
3,760.3100
3,760.3100
4,335.2650
3,013.5340
170.4570
Reconciled Depreciation
534.8880
534.8880
676.5830
578.6680
386.2770
Net Income from Continuing Operation Net Minority Interest
-12,017.2190
-12,017.2190
-11,750.9230
-7,130.9980
-7,077.6190
Total Unusual Items Excluding Goodwill
-1,491.2850
-1,491.2850
-1,964.2120
-204.2770
-22.0450
Total Unusual Items
-1,491.2850
-1,491.2850
-1,964.2120
-204.2770
-22.0450
Normalized EBITDA
-9,939.4240
-9,939.4240
-9,238.9420
-6,364.9630
-6,652.9590
Tax Rate for Calcs
--
--
0.0000
0.0000
--
Tax Effect of Unusual Items
--
--
-26.1135
-0.9161
--
6/30/2021 - 1/2/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BDX.AX BCAL Diagnostics Limited
0.1100
+4.76%
LDX.AX Lumos Diagnostics Holdings Limited
0.0300
-6.25%
CAJ.AX Capitol Health Limited
0.3850
+1.32%
MAP.AX Microba Life Sciences Limited
0.1650
0.00%
GSS.AX Genetic Signatures Limited
0.7100
+2.90%
IIQ.AX INOVIQ Ltd
0.4750
+7.95%
IDX.AX Integral Diagnostics Limited
2.9700
-3.57%
IBX.AX Imagion Biosystems Limited
0.0420
-12.50%
MVF.AX Monash IVF Group Limited
1.1150
-1.33%
ACL.AX Australian Clinical Labs Limited
3.4000
-0.58%